Dr. Glenn Vallecillos, MD, FACS
Medical Doctor (U.S)
Glenn Vallecillos, M.D., F.A.C.S., is a Board Certified Plastic Surgeon in Beverly Hills, California, Principal of DMH Aesthetics Medical Group, and the Co-Founder and Chief Scientific Officer of CannaMedica. He is a Diplomate of the American Board of Plastic Surgery, a Fellow of the American College of Surgeons, and an elected Member of the American Society of Plastic Surgeons.
Doctor Vallecillos has a practice emphasis in minimally-invasive complex facial surgery and revision surgery of the nose and breasts. He is regarded as a pioneer in the adaptation and utilization of combined soft-tissue contraction technologies, allowing for the pinnacle in high-definition facial and body contouring.
Dr. Vallecillos is an active national and international speaker with participating lectures including Plastic Surgery The Meeting( ASPS), IMCAS-Paris, CSFPS, and ISPAN. He is a regular contributor to esteemed publications including the European Journal of Plastic Surgery.
Dr. Vallecillos has served as a Faculty Member of Palette/Scientiae since 2008, recognized as a leading expert in minimally invasive soft-tissue enhancements, having personally trained thousands of top physicians, surgeons and aesthetic medicine practitioners throughout the United States and abroad on advanced injection techniques. Doctor Vallecillos has sat on the Advisory Boards for Allergan, Suneva, and Hans Biomed. He was the Chief Clinical Investigator for the Coapt Systems Novielle Injectable Filler Study, he has worked as a Clinical Investigator for Mentor Corporation, and is a Consultant for Inmode.
His current areas of interest include Stem Cell Translational Medicine and Cellular Reprogramming in its application to Longevity and De-Aging.